|
- Points to Consider in the Development of Seed Stocks of Pluripotent Stem Cells for Clinical Applications: International Stem Cell Banking Initiative (ISCBI), Future Medicine
- Report of the International Conference on Regulatory Endeavors towards the Sound Development of Human Cell Therapy Products, Biologicals
- Data Sharing in Stem Cell Translational Science: Policy Statement by the International Stem Cell Forum Ethics Working Party, Future Medicine
- Reprogrammed Stem Cells Work as Well as Those from Embryos, Science Magazine
- Who Owns Molecular Biology?, Boston Review
- Researchers Identify Potential Alternative to CRISPR-Cas Genome Editing Tools, NIH
- Fetal Cells May Protect Mom from Disease Long After the Baby's Born, NPR
- Vertex Puts $105 Million into Gene Editing Startup, Boston Globe
- CIRM Scholar Helen Fong on Stem Cells and Brain Disease, The Stem Cellar
- NHS Starts 'Stem Cell Factory' for Diabetes, BBC News
- Monkeying Around with Myostatin: On the Road to Healthier Humans or Human Hulks?, Knoepfler Lab Stem Cell Blog
- Embryonic and Man-Made Stem Cells Are Almost Identical, The Stem Cellar
- Eugenics Need Not Be a Dirty Word - Instead, It Could Be Lifesaving Technology, The Telegraph
- UCLA Scientists Find 3000 New Genes in “Junk DNA” of Immune Stem Cells, The Stem Cellar
- Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons, Stem Cell
|
|
|
|
|